Treatment of hepatitis B virus-infected cells with α-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity (Antiviral Research, 2007)

(untitled) - Lazar, C; Durantel, D; Macovei, A; Zitzmann, N; Zoulim, F; Dwek, RA; Branza-Nichita, N